<p>在谷歌搜索和人工智能答案中查看更多来自 StockTitan 的信息。将 StockTitan 添加为首选来源 · 打开谷歌</p>
<p>在谷歌上添加</p>
<p>中国无锡，2026 年 6 月 12 日（全球新闻通讯社）——Park Ha Biological Technology Co., Ltd.（纳斯达克：BYAH），一家根据开曼群岛法律注册的有限责任公司（“公司”），今天宣布已与多位投资者签署证券购买协议，进行注册直接发行的证券销售（“发行”），包括最多 1,133,332 股公司 A 类普通股，面值为每股 0.001 美元（“股份”），以及预先融资的认股权证（“预融资认股权证”），可购买最多 200,000 股 A 类普通股（“认股权证股份”），每股和预融资认股权证的综合购买价格为 1.50 美元。预计公司从此次发行中获得的总收益约为 200 万美元。</p>
<p>此次发行预计将在 2026 年 6 月 15 日左右完成，具体取决于惯例的交割条件。</p>
<p>D. Boral Capital LLC 担任此次发行的唯一配售代理。</p>
<p>公司打算将此次发行的净收益用于一般企业和营运资金用途。</p>
<p>此次发行的证券是根据之前向美国证券交易委员会（“SEC”）提交的有效 “货架” 注册声明（表格 F-3，文件编号 333-295090）进行的，该注册声明于 2026 年 6 月 8 日根据《1933 年证券法》获得批准。与此次发行相关的招股说明书补充文件及相关招股说明书将提交给 SEC，并将在 SEC 的网站 www.sec.gov 上提供。</p>
<p>本新闻稿不构成出售这些证券的要约或购买这些证券的邀请，也不应在任何州或司法管辖区进行这些证券的销售，除非在该州或司法管辖区的证券法下注册或合格的情况下。</p>
<p><strong>关于公司</strong></p>
<p>Park Ha Biological Technology Co., Ltd.成立于 2016 年，主要从事开发其私人护肤品牌 “Park Ha” 的护肤产品，直接销售护肤产品和特许经营联盟推广，致力于为需要皮肤治疗的女性提供具有成本效益的解决方案，提高她们的自信。截至 2025 年 10 月 31 日，公司在中国拥有五家直营店和 22 家特许经营店。作为其产品增值服务的一部分，公司提供 “轻美容体验”，在直营店和特许经营店内进行快速的免费售后美容服务。有关更多信息，请访问公司网站：http://ir.parkha.cn/。</p>
<p><strong>前瞻性声明</strong></p>
<p>本公告中的某些声明是前瞻性声明。这些前瞻性声明涉及已知和未知的风险和不确定性，并基于公司对未来事件的当前预期和预测，认为这些事件可能影响其财务状况、经营结果、商业战略和财务需求。投资者可以通过 “可能”、“将”、“期望”、“预期”、“旨在”、“估计”、“打算”、“计划”、“相信”、“可能会”、“潜在”、“继续” 或其他类似表达来识别这些前瞻性声明。除法律要求外，公司没有义务公开更新或修订任何前瞻性声明，以反映后续发生的事件或情况，或其预期的变化。尽管公司认为这些前瞻性声明中表达的期望是合理的，但无法保证这些期望会正确实现，公司提醒投资者，实际结果可能与预期结果有重大差异，并鼓励投资者查看可能影响其未来结果的其他因素，这些因素在公司的注册声明和其他向 SEC 提交的文件中有所说明。</p>
<p><strong>如需更多信息，请联系：</strong></p>
<p><strong>D. Boral Capital LLC</strong></p>
<p>590 Madison Avenue, 39th Floor</p>
<p>纽约，NY 10022</p>
<p>主要电话：+1 (212) 970-5150</p>
<p>www.dboralcapital.com</p>
<p>info@dboralcapital.com</p>
<p><strong>Park Ha Biological Technology Co., Ltd.</strong></p>
<p>901，C 栋</p>
<p>无锡国际生命科学创新园区二期</p>
<p>196 Jinghui 东路</p>
<p>无锡市新吴区，江苏省</p>
<p>中国 214000</p>
<p>http://ir.parkha.cn/</p>
<p>ir_parkha@163.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjME5qTTFOQ00zTmpVNU9EVTRJelV3TURFMU16ZzBOQT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjME5qTTFOQ00zTmpVNU9EVTRJelV3TURFMU16ZzBOQT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YmJmYmI3ODAtNzI2OC00ZDJmLWJiYzgtZDBlZGRmN2UzYzAxLTUwMDE1Mzg0NC0yMDI2LTA2LTEyLWVu/tiny/Park-Ha-Biological-Technology-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YmJmYmI3ODAtNzI2OC00ZDJmLWJiYzgtZDBlZGRmN2UzYzAxLTUwMDE1Mzg0NC0yMDI2LTA2LTEyLWVu/tiny/Park-Ha-Biological-Technology-.png"/></p>

BYAH

<p>Park Ha Biological Technology Co., Ltd.（纳斯达克代码：BYAH）宣布进行最高达 200 万美元的注册直接发行。该公司将以每单位 1.50 美元的价格出售 A 类普通股和预先融资的认股权证。D. Boral Capital LLC 为本次发行的配售代理，所得款项将用于一般企业用途。此次发行预计将在 2026 年 6 月 15 日左右完成</p>

<p>See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google</p>
<div class="lb-trans"><p>在谷歌搜索和人工智能答案中查看更多来自 StockTitan 的信息。将 StockTitan 添加为首选来源 · 打开谷歌</p>
</div><p>Add on Google</p>
<div class="lb-trans"><p>在谷歌上添加</p>
</div><p>Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company’s securities in a registered direct offering (the “Offering”) consisting of up to 1,133,332 of the Company’s Class A ordinary shares, par value $0.001 each (the “Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A ordinary shares (the “Warrant Shares”), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million.</p>
<div class="lb-trans"><p>中国无锡，2026 年 6 月 12 日（全球新闻通讯社）——Park Ha Biological Technology Co., Ltd.（纳斯达克：BYAH），一家根据开曼群岛法律注册的有限责任公司（“公司”），今天宣布已与多位投资者签署证券购买协议，进行注册直接发行的证券销售（“发行”），包括最多 1,133,332 股公司 A 类普通股，面值为每股 0.001 美元（“股份”），以及预先融资的认股权证（“预融资认股权证”），可购买最多 200,000 股 A 类普通股（“认股权证股份”），每股和预融资认股权证的综合购买价格为 1.50 美元。预计公司从此次发行中获得的总收益约为 200 万美元。</p>
</div><p>The Offering is expected to close on or about June 15, 2026, subject to customary closing conditions.</p>
<div class="lb-trans"><p>此次发行预计将在 2026 年 6 月 15 日左右完成，具体取决于惯例的交割条件。</p>
</div><p>D. Boral Capital LLC is acting as the sole placement agent for the offering.</p>
<div class="lb-trans"><p>D. Boral Capital LLC 担任此次发行的唯一配售代理。</p>
</div><p>The Company intends to use the net proceeds from this Offering for general corporate and working capital purposes.</p>
<div class="lb-trans"><p>公司打算将此次发行的净收益用于一般企业和营运资金用途。</p>
</div><p>The securities in the Offering are being offered pursuant to an effective “shelf” registration statement on Form F-3 (File No. 333-295090) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective on June 8, 2026 under the Securities Act of 1933, as amended (the “Securities Act”). A prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov.</p>
<div class="lb-trans"><p>此次发行的证券是根据之前向美国证券交易委员会（“SEC”）提交的有效 “货架” 注册声明（表格 F-3，文件编号 333-295090）进行的，该注册声明于 2026 年 6 月 8 日根据《1933 年证券法》获得批准。与此次发行相关的招股说明书补充文件及相关招股说明书将提交给 SEC，并将在 SEC 的网站 www.sec.gov 上提供。</p>
</div><p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>
<div class="lb-trans"><p>本新闻稿不构成出售这些证券的要约或购买这些证券的邀请，也不应在任何州或司法管辖区进行这些证券的销售，除非在该州或司法管辖区的证券法下注册或合格的情况下。</p>
</div><p><strong>About the Company</strong></p>
<div class="lb-trans"><p><strong>关于公司</strong></p>
</div><p>Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company’s website: http://ir.parkha.cn/.</p>
<div class="lb-trans"><p>Park Ha Biological Technology Co., Ltd.成立于 2016 年，主要从事开发其私人护肤品牌 “Park Ha” 的护肤产品，直接销售护肤产品和特许经营联盟推广，致力于为需要皮肤治疗的女性提供具有成本效益的解决方案，提高她们的自信。截至 2025 年 10 月 31 日，公司在中国拥有五家直营店和 22 家特许经营店。作为其产品增值服务的一部分，公司提供 “轻美容体验”，在直营店和特许经营店内进行快速的免费售后美容服务。有关更多信息，请访问公司网站：http://ir.parkha.cn/。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “intend”, “plan”, “believe”, “is/are likely to”, “potential”, “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.</p>
<div class="lb-trans"><p>本公告中的某些声明是前瞻性声明。这些前瞻性声明涉及已知和未知的风险和不确定性，并基于公司对未来事件的当前预期和预测，认为这些事件可能影响其财务状况、经营结果、商业战略和财务需求。投资者可以通过 “可能”、“将”、“期望”、“预期”、“旨在”、“估计”、“打算”、“计划”、“相信”、“可能会”、“潜在”、“继续” 或其他类似表达来识别这些前瞻性声明。除法律要求外，公司没有义务公开更新或修订任何前瞻性声明，以反映后续发生的事件或情况，或其预期的变化。尽管公司认为这些前瞻性声明中表达的期望是合理的，但无法保证这些期望会正确实现，公司提醒投资者，实际结果可能与预期结果有重大差异，并鼓励投资者查看可能影响其未来结果的其他因素，这些因素在公司的注册声明和其他向 SEC 提交的文件中有所说明。</p>
</div><p><strong>For more information, please contact:</strong></p>
<div class="lb-trans"><p><strong>如需更多信息，请联系：</strong></p>
</div><p><strong>D. Boral Capital LLC</strong></p>
<div class="lb-trans"><p><strong>D. Boral Capital LLC</strong></p>
</div><p>590 Madison Avenue, 39th Floor</p>
<div class="lb-trans"><p>590 Madison Avenue, 39th Floor</p>
</div><p>New York, NY 10022</p>
<div class="lb-trans"><p>纽约，NY 10022</p>
</div><p>Main Phone: +1 (212) 970-5150</p>
<div class="lb-trans"><p>主要电话：+1 (212) 970-5150</p>
</div><p>www.dboralcapital.com</p>
<div class="lb-trans"><p>www.dboralcapital.com</p>
</div><p>info@dboralcapital.com</p>
<div class="lb-trans"><p>info@dboralcapital.com</p>
</div><p><strong>Park Ha Biological Technology Co., Ltd.</strong></p>
<div class="lb-trans"><p><strong>Park Ha Biological Technology Co., Ltd.</strong></p>
</div><p>901, Building C</p>
<div class="lb-trans"><p>901，C 栋</p>
</div><p>Phase 2, Wuxi International Life Science Innovation Campus</p>
<div class="lb-trans"><p>无锡国际生命科学创新园区二期</p>
</div><p>196 Jinghui East Road</p>
<div class="lb-trans"><p>196 Jinghui 东路</p>
</div><p>Xinwu District, Wuxi, Jiangsu Province</p>
<div class="lb-trans"><p>无锡市新吴区，江苏省</p>
</div><p>People’s Republic of China 214000</p>
<div class="lb-trans"><p>中国 214000</p>
</div><p>http://ir.parkha.cn/</p>
<div class="lb-trans"><p>http://ir.parkha.cn/</p>
</div><p>ir_parkha@163.com</p>
<div class="lb-trans"><p>ir_parkha@163.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjME5qTTFOQ00zTmpVNU9EVTRJelV3TURFMU16ZzBOQT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTc0NjM1NCM3NjU5ODU4IzUwMDE1Mzg0NA=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YmJmYmI3ODAtNzI2OC00ZDJmLWJiYzgtZDBlZGRmN2UzYzAxLTUwMDE1Mzg0NC0yMDI2LTA2LTEyLWVu/tiny/Park-Ha-Biological-Technology-.png" alt="" original-src="https://ml.globenewswire.com/media/YmJmYmI3ODAtNzI2OC00ZDJmLWJiYzgtZDBlZGRmN2UzYzAxLTUwMDE1Mzg0NC0yMDI2LTA2LTEyLWVu/tiny/Park-Ha-Biological-Technology-.png"/></p>

Park Ha Biological Technology Co., Ltd. 宣布 200 万美元注册直接发行的定价 | PHH 股票新闻